These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38709266)

  • 1. Atractylenolide II regulates the proliferation, ferroptosis, and immune escape of hepatocellular carcinoma cells by inactivating the TRAF6/NF-κB pathway.
    Lin Y; Chen K; Zhu M; Song W; Wu G; Pan A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7697-7710. PubMed ID: 38709266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obovatol inhibits proliferation, invasion and immune escape of hepatocellular carcinoma cells through modulating the JAK/STST3/PD-L1 pathway.
    Liao C; Zhao M; Jiang X; Sun W; Zeng Q; Cai C; Yin X
    Int Immunopharmacol; 2024 Nov; 141():112775. PubMed ID: 39146776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asiaticoside promoted ferroptosis and suppressed immune escape in gastric cancer cells by downregulating the Wnt/β-catenin pathway.
    Ye C; Yao Z; Wang Y; Zhang C
    Int Immunopharmacol; 2024 Jun; 134():112175. PubMed ID: 38733821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway.
    Liu X; Liu T; Zhou Z; Bian K; Qiu C; Zhang F
    Biochem Biophys Res Commun; 2024 Nov; 734():150762. PubMed ID: 39353360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIGU promotes hepatocellular carcinoma progression through activating NF-κB pathway and increasing immune escape.
    Wei X; Yang W; Zhang F; Cheng F; Rao J; Lu L
    Life Sci; 2020 Nov; 260():118476. PubMed ID: 32971102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3.
    Wan Y; Cheng J; Gan D; He J; Chen A; Ma J; Li Y; Wang X; Ran J; Chen D; Li J
    Chem Biol Drug Des; 2024 Jun; 103(6):e14565. PubMed ID: 38862254
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Shi Y; Yang X; Jiang H; Wu S; Hong Y; Su W; Wang X
    Allergol Immunopathol (Madr); 2024; 52(5):21-28. PubMed ID: 39278847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthocyanins Derived from
    Kim MJ; Paramanantham A; Lee WS; Yun JW; Chang SH; Kim DC; Park HS; Choi YH; Kim GS; Ryu CH; Shin SC; Hong SC
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrobium nobile active ingredient Dendrobin A against hepatocellular carcinoma via inhibiting nuclear factor kappa-B signaling.
    Yu Y; Fan Y; Mei W; Xu X; Chen Y; Zhao Y; Ruan B; Shen Z; Lu Y; Zheng S; Jie W
    Biomed Pharmacother; 2024 Aug; 177():117013. PubMed ID: 38901205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the mechanism of ferroptosis induction by sappanone A in hepatocellular carcinoma: NRF2/xCT/GPX4 axis.
    Xing Y; Yang H; Dai C; Qiu Z; Guan Y; Zhang L
    Eur J Pharmacol; 2024 Nov; 983():176965. PubMed ID: 39214275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.
    Liu Y; Qi Y; Bai ZH; Ni CX; Ren QH; Xu WH; Xu J; Hu HG; Qiu L; Li JZ; He ZG; Zhang JP
    Acta Pharmacol Sin; 2017 Jan; 38(1):120-132. PubMed ID: 27773936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway.
    Tian X; Liu F; Wang Z; Zhang J; Liu Q; Zhang Y; Zhang D; Huang C; Zhao J; Jiang S
    J Ethnopharmacol; 2024 Mar; 322():117577. PubMed ID: 38104877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling.
    Tian J; Li J; Bie B; Sun J; Mu Y; Shi M; Zhang S; Kong G; Li Z; Guo Y
    Toxicol Appl Pharmacol; 2021 Jun; 420():115522. PubMed ID: 33838155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
    Guo L; Li H; Fan T; Ma Y; Wang L
    Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells.
    Yang Y; Liu C; Wang M; Cheng H; Wu H; Luo S; Zhang M; Duan X; Li Q
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4895-4909. PubMed ID: 38165425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity.
    Tao Z; Ruan H; Sun L; Kuang D; Song Y; Wang Q; Wang T; Hao Y; Chen K
    Cancer Immunol Res; 2019 Jul; 7(7):1135-1147. PubMed ID: 31113805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway.
    Ji J; Cheng Z; Zhang J; Wu J; Xu X; Guo C; Feng J
    J Cell Mol Med; 2024 Apr; 28(8):e18335. PubMed ID: 38652216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.